Geneva Partners’s Affirm AFRM Stock Holding History

Geneva Partners’s Portfolio AFRM Stock Details AFRM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-6,200	Closed	-$739K	–	98
2021 Q3	$739K	Buy	+6,200	New	+$495K	0.35%	53

Other funds holding AFRM

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

VK Services Menlo Park, California $543K AUM 174.84% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

GGV Capital Menlo Park, California $115M AUM 24.14% 1-Year Est. Return

Geneva Partners's AFRM Position: Q4 2021 in Review

Geneva Partners sold out of Affirm (AFRM) in Q4 2021, closing a stake of 6,200 shares — an estimated $739K sold.

Geneva Partners first reported a position in AFRM in Q3 2021 and held it in 1 quarter. The position peaked at $739K in Q3 2021. 438 funds tracked by Wall St. Rank hold AFRM as of Q4 2021.

Geneva Partners reported no remaining Affirm position as of Q4 2021 after selling out during the quarter.
Geneva Partners sold 6,200 Affirm shares in Q4 2021, an estimated $739K.
Geneva Partners first reported a position in Affirm in Q3 2021 and held it in 1 quarter.
Geneva Partners's Affirm position peaked at $739K in Q3 2021.
438 funds tracked by Wall St. Rank held Affirm as of Q4 2021.

Based on Geneva Partners's 13F filing for Q4 2021, filed 31 Jan 2022.